Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Utrecht, Netherlands Clinical Trials

A listing of Utrecht, Netherlands clinical trials actively recruiting patients volunteers.

RESULTS

Found (4) clinical trials

A Phase 2 Study of BGJ398 in Patients With Recurrent GBM

Patients will be enrolled in two groups. Group 1 will enroll patients who are not candidates for surgery. Group 2 will enroll patients who are surgical candidates. Patients from both groups will be evaluated for tumor response and progression by MRI every 8 weeks until disease progression or discontinuation from ...

Phase

0.0 miles

Learn More »

A Study Looking at the Safety Tolerability and Efficacy of the Combination of the Study Drugs GLPG2451 and GLPG2222 With or Without GLPG2737 in Patients With Cystic Fibrosis.

This is a Phase Ib, multi-center, open-label, nonrandomized multiple cohorts study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple doses of a combination treatment of GLPG2451 and GLPG2222, with and without GLPG2737, in adult subjects with Cystic Fibrosis.

Phase

0.0 miles

Learn More »

Serial Multiparametric Evaluation of Right Ventricular Function After Left Ventricular Assist Device Implantation

The study consists of 2 parts: a Pilot study and a Main Study as detailed below. The purpose of the Pilot study is to evaluate the feasibility of RV quantification using two-, three-dimensional and Multiplane echocardiography. About 100 subjects undergoing LVAD implantation in the European Registry for Patients with Mechanical ...

Phase N/A

0.0 miles

Learn More »

BioDay Registry: Data Collection Regarding Dupixent in Patients With Atopic Dermatitis in Daily Practice

Atopic Dermatitis (AD) is the most common chronic inflammatory skin disease in the Netherlands with more than 400.000 patients suffering from this disease. For patients with difficult to treat AD, treatment options are limited. Although the Dutch AD Guideline recommends oral immunosuppressive drugs in difficult to treat AD, both label ...

Phase N/A

2.46 miles

Learn More »